(Total Views: 494)
Posted On: 06/03/2019 9:10:42 PM
Post# of 145921
Thank you ohm, I remember you stating that with leronlimab CD8 increases.....and remember from the videos on the CytoDyn website that leronlimab binds a specific spot on the CCR5 while still allowing functionality whereas other CCR5 antagonists are ‘deep buried’ and block all entry into the receptor.
I know some conversations I had on SA where this was a concern if leronlimab would have success in cancer (like maraviroc showed) due to not blocking the entire receptor? Time will tell, but based on preclinical comparisons things look promising.
I know some conversations I had on SA where this was a concern if leronlimab would have success in cancer (like maraviroc showed) due to not blocking the entire receptor? Time will tell, but based on preclinical comparisons things look promising.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.